Brevia Health deepens vaccines expertise with Nick Lowen appointment

Brevia Health has deepened our vaccines expertise with the appointment of Nick Lowen as an Associate with over 30 years’ life sciences experience including serving as Vice President, Commercial Strategic Projects at GSK.  During his time at GSK, Nick successfully led complex negotiations including the introduction of innovative vaccines for the UK and other European markets.  As Vice Chair of the UK Industry Vaccines Group, he oversaw the development of the ABPI position on market access and response to the DHSC CEMIPP report.  Nick joins our senior team of advisers that include Gillian Leng CBE (former CEO, NICE), Jonathan Mogford (former Director of Policy, MHRA) and Mike Thompson MBE (former CEO, ABPI).

Nick trained as a pharmacist and began his career in the NHS.  Before joining the Biopharma industry, he was one of the UK’s first regional NHS Pharmaceutical advisers.

He joined GSK in 1997 where he worked for over 25 years and held a number of senior leadership roles.  During this period, he successfully led complex negotiations including the introduction of innovative vaccines for the UK and other European markets.  As Vice Chair of the UK Industry Vaccines Group, Nick oversaw the development of the ABPI position on market access and response to the DHSC CEMIPP report.

In addition to Vaccines, Nick has therapeutic experience in Neurology, Dermatology, Anti-infectives, Respiratory, Oncology and specialist medicines.

Nick has a passion for delivering marketing and sales excellence across Global, EU and UK Pharmaceutical markets through launching innovative products, life cycle management and building market access.  He has a strong track record managing teams to create and deliver strategic business change in Pharma, including managing the transition to outsource operations in multiple countries, creating business development opportunities, and negotiating and concluding significant business deals.

 

BREVIA HEALTH PROVIDES STRAIGHTFOWARD PUBLIC AFFAIRS AND PUBLIC RELATIONS SUPPORT TO BUSINESSES AND CHARITIES OPERATING IN THE HIGHLY REGULATED UK HEALTHCARE SECTOR

Discover how Brevia can help you and your organisation by viewing our Health services or contacting the Brevia Team on 020 7091 1650 or emailing us at contact@brevia.co.uk

 

 

 

 

 

LATEST NEWS

photovoltaic, photovoltaic system, solar system, solar, solar energy, solar cell, power generation, solar panel, energy transition, energy, electricity, solar power, renewable, solar field, solar cells, nature, sun, heaven, voltage, technology, environment, power supply, light, clouds, renewable energy
Energy

The Solar Roadmap 2025: Ambitions and Obstacles

Since the UK Government published its ‘Solar Roadmap 2025’ in June, Reform UK has launched a direct counter-campaign. Brevia Energy assesses the implications of this political tension and whether it translates into real project risk or whether rhetoric outpaces reality.

Read More »
City of London
General

How investors can manage political risk in the UK market

Most investors have long recognised the role UK government policy, regulatory change and stakeholder scrutiny can have on their investments. But with electoral politics now changing as rapidly as financial and operational environments, politics is increasingly shaping deal outcomes and portfolio value.

Read More »